Form 4 holding
Chief Executive Officer, Director
Artemis Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 15,665,690
- Estimated value
- Report date
- 30 Jun 2022
- Price
- Ownership
- Direct
Shimon Citron
Insider Reports History
- Latest reporting-owner signature
-
/s/ Shimon Citron
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Shimon Citron
Form 4 holding
Chief Executive Officer, Director
Artemis Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 10,443,793
- Estimated value
- Report date
- 30 Jun 2022
- Price
- Ownership
- By Spouse
Insider Reports Filed by Shimon Citron
3
Artemis Therapeutics, Inc.
- Report period
- 30 Jun 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 12 Aug 2022, 16:05
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details